Clinical Trial Update: GnRH Agonist and Intrauterine Insemination [Phase 4]

View source ↗

Summary

Announces the completion of a Phase 4 clinical trial evaluating a GnRH agonist used with intrauterine insemination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• GnRH agonist (gonadotropin-releasing hormone agonist)

Snippet

Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA | Conditions: Intrauterine Insemination | Phase 4 | Status: COMPLETED